Literature DB >> 3262686

Inhibition of lipopolysaccharide activation of 7OZ/3 cells by anti-lipopolysaccharide antibodies.

T N Kirkland1, E J Ziegler, P Tobias, D C Ward, S M Michalek, J R McGhee, I Macher, K Urayama, B J Appelmelk.   

Abstract

We have investigated the ability of mAb against LPS to inhibit LPS-induced activation of 7OZ/3 pre-B cells. The fine specificity and relative affinity of these mAb for lipid A and LPS were also determined. We found that antibodies inhibited only the activity of glycolipids which they bound with relatively high affinity. However, two high affinity antibodies binding to non-lipid A epitopes did not block cellular activation. Some, but not all, relatively high affinity antibodies binding to the lipid A region of the LPS molecule inhibited biologic activity. The inhibitory antibodies bound to at least two distinct epitopes within the lipid A region. These data suggest that LPS interacts with 7OZ/3 cells in a highly specific fashion.

Entities:  

Mesh:

Substances:

Year:  1988        PMID: 3262686

Source DB:  PubMed          Journal:  J Immunol        ISSN: 0022-1767            Impact factor:   5.422


  3 in total

1.  Scavenger receptor pathway for lipopolysaccharide binding to Kupffer and endothelial liver cells in vitro.

Authors:  A Shnyra; A A Lindberg
Journal:  Infect Immun       Date:  1995-03       Impact factor: 3.441

2.  Lipopolysaccharidelike immunological properties of cell wall glycoproteins isolated from Cytophaga johnsonae.

Authors:  D M de Jong; J L Pate; T N Kirkland; C E Taylor; P J Baker; K Takayama
Journal:  Infect Immun       Date:  1991-08       Impact factor: 3.441

3.  Diphosphoryl lipid A derived from lipopolysaccharide (LPS) of Rhodopseudomonas sphaeroides inhibits activation of 70Z/3 cells by LPS.

Authors:  T N Kirkland; N Qureshi; K Takayama
Journal:  Infect Immun       Date:  1991-01       Impact factor: 3.441

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.